RU2009100649A - METHOD FOR CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR KIND OF AGE CATARACT - Google Patents

METHOD FOR CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR KIND OF AGE CATARACT Download PDF

Info

Publication number
RU2009100649A
RU2009100649A RU2009100649/14A RU2009100649A RU2009100649A RU 2009100649 A RU2009100649 A RU 2009100649A RU 2009100649/14 A RU2009100649/14 A RU 2009100649/14A RU 2009100649 A RU2009100649 A RU 2009100649A RU 2009100649 A RU2009100649 A RU 2009100649A
Authority
RU
Russia
Prior art keywords
nuclear
conservative treatment
age
prevention
cataract
Prior art date
Application number
RU2009100649/14A
Other languages
Russian (ru)
Other versions
RU2411926C2 (en
Inventor
Надежда Витальевна Корсакова (RU)
Надежда Витальевна Корсакова
Original Assignee
Надежда Витальевна Корсакова (RU)
Надежда Витальевна Корсакова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Надежда Витальевна Корсакова (RU), Надежда Витальевна Корсакова filed Critical Надежда Витальевна Корсакова (RU)
Priority to RU2009100649/15A priority Critical patent/RU2411926C2/en
Publication of RU2009100649A publication Critical patent/RU2009100649A/en
Application granted granted Critical
Publication of RU2411926C2 publication Critical patent/RU2411926C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Способ консервативного лечения и профилактики ядерного вида возрастной катаракты, отличающийся тем, что путем использования антагонистов серотониновых рецепторов в составе лекарственных форм для местного лечения заболеваний глаз производится патогенетически обоснованное воздействие на биоаминный статус и фенотип клеток хрусталика. A method of conservative treatment and prophylaxis of a nuclear type of age-related cataract, characterized in that by using antagonists of serotonin receptors as part of dosage forms for the local treatment of eye diseases, pathogenetically substantiated effects on the bioamine status and phenotype of lens cells are made.

Claims (1)

Способ консервативного лечения и профилактики ядерного вида возрастной катаракты, отличающийся тем, что путем использования антагонистов серотониновых рецепторов в составе лекарственных форм для местного лечения заболеваний глаз производится патогенетически обоснованное воздействие на биоаминный статус и фенотип клеток хрусталика. A method of conservative treatment and prophylaxis of a nuclear type of age-related cataract, characterized in that by using antagonists of serotonin receptors as part of dosage forms for the local treatment of eye diseases, pathogenetically substantiated effects on the bioamine status and phenotype of lens cells are made.
RU2009100649/15A 2009-01-13 2009-01-13 Method of conservative treatment and prevention of nuclear type of age cataract RU2411926C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2009100649/15A RU2411926C2 (en) 2009-01-13 2009-01-13 Method of conservative treatment and prevention of nuclear type of age cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2009100649/15A RU2411926C2 (en) 2009-01-13 2009-01-13 Method of conservative treatment and prevention of nuclear type of age cataract

Publications (2)

Publication Number Publication Date
RU2009100649A true RU2009100649A (en) 2010-07-20
RU2411926C2 RU2411926C2 (en) 2011-02-20

Family

ID=42685596

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009100649/15A RU2411926C2 (en) 2009-01-13 2009-01-13 Method of conservative treatment and prevention of nuclear type of age cataract

Country Status (1)

Country Link
RU (1) RU2411926C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2536958C2 (en) * 2012-11-14 2014-12-27 Открытое Акционерное Общество "Татхимфармпрепараты" Drug preparation for treating cataract and method for preparing it (versions)
RU2637875C2 (en) * 2015-09-21 2017-12-07 Надежда Витальевна Корсакова New eye droplets for conservative treatment and prevention of the age-related nuclear cataract
RU2720676C2 (en) * 2019-07-22 2020-05-12 Надежда Витальевна Корсакова Eye drops for treating age-related nuclear cataract
RU2748598C1 (en) * 2020-09-15 2021-05-27 Надежда Витальевна Корсакова Improved eye drops for prevention and treatment of early manifestations of age-related nuclear cataract

Also Published As

Publication number Publication date
RU2411926C2 (en) 2011-02-20

Similar Documents

Publication Publication Date Title
CY1119474T1 (en) Crystalline Forms of 5-Chloro-N2- (2-Isopropoxy-5-Methyl-4-Piperidin-4-yl-phenyl) -N4 [2- (Propane-2-Sulfonyl) -finyl] 2-phenyl
EA201590092A1 (en) NITROGEN-CONTAINING 5-MEMBER HETEROCYCLES FIXED BY CARBOXAMIDE OR SULPHONAMIDE AS MODULATORS FOR THE NUCLEAR ORPHAN RORγ RECEPTOR
EA201791239A8 (en) TETRAHYDROPYRIDO [3,4-b] INDOL MODELERS OF ESTROGEN RECEPTORS AND THEIR APPLICATION
BR112012033176A2 (en) device for disinfecting contact lenses stored in a case
MX2014000629A (en) Intraocular implant cell migration inhibition system.
EA201591405A1 (en) SPIROLACTAM NMDA-RECEPTOR MODULATORS AND THEIR APPLICATION
CO7250451A2 (en) Ophthalmic formulation and method to mitigate presbyopia
UY32819A (en) PHARMACEUTICAL COMPOSITIONS OF OPTALMIC USE OF ANTAGONISTS OF DP2 RECEIVER
EA201071291A2 (en) NMDA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NEUROPSYATRIC DISORDERS
EA201300869A1 (en) MORPHINAN COMPOUNDS
MX2018010852A (en) Methods of treating depression using orexin-2 receptor antagonists.
EA201100409A1 (en) SUBSTITUTED DERIVATIVES OF TRIAZOLOPIRIDAZIN
EA201390977A1 (en) COMBINATION OF OPIOID RECEPTOR AGONIST AND OPIOID RECEPTOR ANTAGONIST FOR THE TREATMENT OF PARKINSON'S Disease
WO2013166037A9 (en) Non-retinoid antagonists for treatment of eye disorders
GT201500035A (en) ORAL PHARMACEUTICAL COMPOSITION IN THE FORM OF MICROSPHERES AND ELABORATION PROCESS
RU2009100649A (en) METHOD FOR CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR KIND OF AGE CATARACT
AR086395A1 (en) PACKAGE FOR TREATMENT OF PATHOLOGIES
AR092103A1 (en) LAQUINIMOD IN THE TREATMENT OF DISORDERS MEDIATED BY THE CANABINOID RECEIVER OF TYPE 1 (CB1)
JO3128B1 (en) Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
AR069233A1 (en) ANTI-FACTOR B ANTIBODIES AND THEIR USES
EA201992004A1 (en) METHODS FOR PREVENTING OR TREATING OPHTHALMIC DISEASES
RU2015139946A (en) New eye drops for conservative treatment and prevention of age-related nuclear cataracts
MX2016007795A (en) Use of par-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions.
RU2013147081A (en) IMPLANT FOR INTRODUCTION IN THE HUNGARY POCKET OF THE HUMAN EYE FOR THE CORRECTION OF REFRACTION ANOMALIES
MX2016007717A (en) Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof.